Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Skye Bioscience Uplists to The Nasdaq Global Market
Read Article
News
2024
2023
Archive
Search news articles
July 16, 2020
Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 15, 2020
Vor Biopharma Appoints Dr. Christopher Slapak as Chief Medical Officer
July 14, 2020
Pear Therapeutics Announces First Participant Enrolled in Virtual Real-World Study of Adults with Chronic Insomnia
July 10, 2020
IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor
July 7, 2020
Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies
July 7, 2020
Pear Therapeutics Announces $50 Million Credit Facility From Perceptive Advisors
July 7, 2020
Vor Biopharma Closes $110 Million Series B Financing
July 1, 2020
scPharmaceuticals Announces FUROSCIX® NDA Resubmission
June 30, 2020
Impel Neuropharma Announces Publication of Positive Results of SNAP 101 Study for INP105 for the Treatment of Acute Agitation in the Journal of Clinical Psyciatry
June 29, 2020
Cidara Therapeutics Added to Russell 3000® Index
« Previous Page
1
…
52
53
54
55
56
…
118
Next Page »